Sunzen Biotech Berhad reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was MYR 27.74 million compared to MYR 20.35 million a year ago. Net income was MYR 0.803 million compared to MYR 0.178 million a year ago. Basic earnings per share from continuing operations was MYR 0.0012 compared to MYR 0.0003 a year ago. Diluted earnings per share from continuing operations was MYR 0.0011 compared to MYR 0.0003 a year ago.
For the six months, sales was MYR 56.17 million compared to MYR 44 million a year ago. Net income was MYR 1.54 million compared to net loss of MYR 0.04 million a year ago. Basic earnings per share from continuing operations was MYR 0.0024 compared to basic loss per share from continuing operations of MYR 0.0001 a year ago. Diluted earnings per share from continuing operations was MYR 0.0021 compared to diluted loss per share from continuing operations of MYR 0.0001 a year ago.